Pediatric inflammatory bowel disease and bone health.
Study Goal
The researchers aimed to evaluate the role of calcium supplementation in managing bone health abnormalities in patients with inflammatory bowel disease.
Results Summary
The study suggests that calcium supplementation, along with vitamin D and disease control, is a limited but important treatment option for improving bone health in at-risk patients. The role of bisphosphonates requires further study.
Population
Patients with inflammatory bowel disease, particularly children and adolescents.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
vitamin D and calcium supplementation | neutral | bone health abnormalities | patients with inflammatory bowel disease | - | treatment options are limited to | #1 |
control of underlying disease activity | neutral | bone health abnormalities | patients with inflammatory bowel disease | - | treatment options are limited to | #2 |
appropriate physical activity | neutral | bone health abnormalities | patients with inflammatory bowel disease | - | treatment options are limited to | #3 |
Childhood and adolescence are important periods for bone development. Any disease that affects bone health has the potential to affect the bones not only in the short term but also later in life. Bone health abnormalities in patients with inflammatory bowel disease are being increasingly recognized. Screening the at-risk patient is important so that appropriate treatments can be instituted. Treatment options are limited to vitamin D and calcium supplementation, control of underlying disease activity, and appropriate physical activity. The role of bisphosphonates in these patients needs to be better studied, and treatment with bisphosphonates may be considered for some patients in consultation with a bone health expert.